Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr;184(4):770-772.
doi: 10.1111/bjd.19684. Epub 2020 Dec 28.

Secukinumab for the treatment of SAM syndrome associated with desmoglein-1 deficiency

Affiliations

Secukinumab for the treatment of SAM syndrome associated with desmoglein-1 deficiency

L H Frommherz et al. Br J Dermatol. 2021 Apr.
No abstract available

PubMed Disclaimer

References

    1. Samuelov L, Sarig O, Harmon RM et al. Desmoglein 1 deficiency results in severe dermatitis, multiple allergies and metabolic wasting. Nat Genet 2013; 45:1244-8.
    1. Taiber S, Samuelov L, Mohamad J et al. SAM syndrome is characterized by extensive phenotypic heterogeneity. Exp Dermatol 2018; 27:787-90.
    1. Has C, Jakob T, He Y et al. Loss of desmoglein 1 associated with palmoplantar keratoderma, dermatitis and multiple allergies. Br J Dermatol 2015; 172:257-61.
    1. McAleer MA, Pohler E, Smith FJD et al. Severe dermatitis, multiple allergies, and metabolic wasting syndrome caused by a novel mutation in the N-terminal plakin domain of desmoplakin. J Allergy Clin Immunol 2015; 136:1268-76.
    1. Hernández-Martín A, Kennedy-Batalla R, Cañedo E et al. Imbalance in T-Helper 17 Cells and targeted therapy in an infant with SAM-like syndrome. N Engl J Med 2019; 381:2176-8.

Publication types